Loading…
Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii
A rare but lethal central nervous system disease known as granulomatous amoebic encephalitis (GAE) and potentially blinding Acanthamoeba keratitis are diseases caused by free-living Acanthamoeba. Currently, no therapeutic agent can completely eradicate or prevent GAE. Synthetic compounds are a likel...
Saved in:
Published in: | Heliyon 2024-01, Vol.10 (1), p.e23258-e23258, Article e23258 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c482t-4c473b46ce403bc20052eda8813b75a528c793daca8ac0b14572185354123623 |
container_end_page | e23258 |
container_issue | 1 |
container_start_page | e23258 |
container_title | Heliyon |
container_volume | 10 |
creator | Alishba Ahmed, Usman Taha, Muhammad Khan, Naveed Ahmed Salar, Uzma Khan, Khalid Mohammed Anwar, Ayaz Siddiqui, Ruqaiyyah |
description | A rare but lethal central nervous system disease known as granulomatous amoebic encephalitis (GAE) and potentially blinding Acanthamoeba keratitis are diseases caused by free-living Acanthamoeba. Currently, no therapeutic agent can completely eradicate or prevent GAE. Synthetic compounds are a likely source of bioactive compounds for developing new drugs. This study synthesized seventeen 1,4-benzothiazine derivatives (I –XVII) by a base-catalyzed one-pot reaction of 2-amino thiophenol with substituted bromo acetophenones. Different spectroscopic techniques, such as EI-MS, 1H-, and 13C NMR (only for the new compounds), were used for the structural characterization and conformation of compounds. These compounds were assessed for the first time against Acanthamoeba castellanii. All compounds showed anti-amoebic potential in vitro against A. castellanii, reducing its ability to encyst and excyst at 100 μM. Compounds IX, X, and XVI showed the most potent activities among all derivatives and significantly reduced the viability to 5.3 × 104 (p |
doi_str_mv | 10.1016/j.heliyon.2023.e23258 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_89b62601f2ec41b89647b81fd1a240ac</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S240584402310466X</els_id><doaj_id>oai_doaj_org_article_89b62601f2ec41b89647b81fd1a240ac</doaj_id><sourcerecordid>2913451506</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-4c473b46ce403bc20052eda8813b75a528c793daca8ac0b14572185354123623</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhiMEolXpTwDlyIEs_o5zQlXFR6VKcOjdGjuTjaNsXGzvSttfj7u7lPbEaazxzDMz71tV7ylZUULV52k14uz3YVkxwvgKGWdSv6rOmSCy0UKQ18_eZ9VlShMhhEqtupa_rc64ZkQyLc-r6VfIuGQPcw0lNLAJaL2rcRjQ5VSHoU77JY-YS5J-Eo3F5SHk0cODX7DuMfodZL_DVMMa_JJyfeUKaTyAoHaQMs4zLN6_q94MMCe8PMWL6u7b17vrH83tz-8311e3jROa5UY40XIrlENBuHWMlE2xB60pt62EsrZrO96DAw2OWCpky6iWXArKuGL8oro5YvsAk7mPfgNxbwJ4c0iEuDYQyzUzGt1ZxRShA0MnqNWdEq3VdOgpFPXAFdaXI-t-azfYu6JUhPkF9OXP4kezDjtDSduqTtJC-HgixPB7iymbjU_uoAiGbTKso1xIKokqpfJY6mJIKeLwNIcS82i7mczJdvNouznaXvo-PF_yqeuvyf-uwKL6zmM0yXlcHPY-FpOLLv4_I_4AcTDCiA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2913451506</pqid></control><display><type>article</type><title>Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii</title><source>Open Access: PubMed Central</source><source>ScienceDirect®</source><creator>Alishba ; Ahmed, Usman ; Taha, Muhammad ; Khan, Naveed Ahmed ; Salar, Uzma ; Khan, Khalid Mohammed ; Anwar, Ayaz ; Siddiqui, Ruqaiyyah</creator><creatorcontrib>Alishba ; Ahmed, Usman ; Taha, Muhammad ; Khan, Naveed Ahmed ; Salar, Uzma ; Khan, Khalid Mohammed ; Anwar, Ayaz ; Siddiqui, Ruqaiyyah</creatorcontrib><description>A rare but lethal central nervous system disease known as granulomatous amoebic encephalitis (GAE) and potentially blinding Acanthamoeba keratitis are diseases caused by free-living Acanthamoeba. Currently, no therapeutic agent can completely eradicate or prevent GAE. Synthetic compounds are a likely source of bioactive compounds for developing new drugs. This study synthesized seventeen 1,4-benzothiazine derivatives (I –XVII) by a base-catalyzed one-pot reaction of 2-amino thiophenol with substituted bromo acetophenones. Different spectroscopic techniques, such as EI-MS, 1H-, and 13C NMR (only for the new compounds), were used for the structural characterization and conformation of compounds. These compounds were assessed for the first time against Acanthamoeba castellanii. All compounds showed anti-amoebic potential in vitro against A. castellanii, reducing its ability to encyst and excyst at 100 μM. Compounds IX, X, and XVI showed the most potent activities among all derivatives and significantly reduced the viability to 5.3 × 104 (p < 0.0003), 2 × 105 (p < 0.006), and 2.4 × 105 (p < 0.002) cells/mL, respectively. The cytotoxicity profile revealed that these molecules showed lower to moderate cytotoxicity, i.e., 36 %, 2 %, and 21 %, respectively, against human keratinocytes in vitro. These results indicate that 1,4-benzothiazines showed potent in vitro activity against trophozoites and cysts of A. castellanii. Hence, these 1,4-benzothiazine derivatives should be considered to develop new potential therapeutic agents against Acanthamoeba infections.</description><identifier>ISSN: 2405-8440</identifier><identifier>EISSN: 2405-8440</identifier><identifier>DOI: 10.1016/j.heliyon.2023.e23258</identifier><identifier>PMID: 38205285</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acanthamoeba ; Amoebicidal ; Benzothiazine ; One-pot synthesis</subject><ispartof>Heliyon, 2024-01, Vol.10 (1), p.e23258-e23258, Article e23258</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors.</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c482t-4c473b46ce403bc20052eda8813b75a528c793daca8ac0b14572185354123623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776951/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S240584402310466X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3548,27923,27924,45779,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38205285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alishba</creatorcontrib><creatorcontrib>Ahmed, Usman</creatorcontrib><creatorcontrib>Taha, Muhammad</creatorcontrib><creatorcontrib>Khan, Naveed Ahmed</creatorcontrib><creatorcontrib>Salar, Uzma</creatorcontrib><creatorcontrib>Khan, Khalid Mohammed</creatorcontrib><creatorcontrib>Anwar, Ayaz</creatorcontrib><creatorcontrib>Siddiqui, Ruqaiyyah</creatorcontrib><title>Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii</title><title>Heliyon</title><addtitle>Heliyon</addtitle><description>A rare but lethal central nervous system disease known as granulomatous amoebic encephalitis (GAE) and potentially blinding Acanthamoeba keratitis are diseases caused by free-living Acanthamoeba. Currently, no therapeutic agent can completely eradicate or prevent GAE. Synthetic compounds are a likely source of bioactive compounds for developing new drugs. This study synthesized seventeen 1,4-benzothiazine derivatives (I –XVII) by a base-catalyzed one-pot reaction of 2-amino thiophenol with substituted bromo acetophenones. Different spectroscopic techniques, such as EI-MS, 1H-, and 13C NMR (only for the new compounds), were used for the structural characterization and conformation of compounds. These compounds were assessed for the first time against Acanthamoeba castellanii. All compounds showed anti-amoebic potential in vitro against A. castellanii, reducing its ability to encyst and excyst at 100 μM. Compounds IX, X, and XVI showed the most potent activities among all derivatives and significantly reduced the viability to 5.3 × 104 (p < 0.0003), 2 × 105 (p < 0.006), and 2.4 × 105 (p < 0.002) cells/mL, respectively. The cytotoxicity profile revealed that these molecules showed lower to moderate cytotoxicity, i.e., 36 %, 2 %, and 21 %, respectively, against human keratinocytes in vitro. These results indicate that 1,4-benzothiazines showed potent in vitro activity against trophozoites and cysts of A. castellanii. Hence, these 1,4-benzothiazine derivatives should be considered to develop new potential therapeutic agents against Acanthamoeba infections.</description><subject>Acanthamoeba</subject><subject>Amoebicidal</subject><subject>Benzothiazine</subject><subject>One-pot synthesis</subject><issn>2405-8440</issn><issn>2405-8440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkU1v1DAQhiMEolXpTwDlyIEs_o5zQlXFR6VKcOjdGjuTjaNsXGzvSttfj7u7lPbEaazxzDMz71tV7ylZUULV52k14uz3YVkxwvgKGWdSv6rOmSCy0UKQ18_eZ9VlShMhhEqtupa_rc64ZkQyLc-r6VfIuGQPcw0lNLAJaL2rcRjQ5VSHoU77JY-YS5J-Eo3F5SHk0cODX7DuMfodZL_DVMMa_JJyfeUKaTyAoHaQMs4zLN6_q94MMCe8PMWL6u7b17vrH83tz-8311e3jROa5UY40XIrlENBuHWMlE2xB60pt62EsrZrO96DAw2OWCpky6iWXArKuGL8oro5YvsAk7mPfgNxbwJ4c0iEuDYQyzUzGt1ZxRShA0MnqNWdEq3VdOgpFPXAFdaXI-t-azfYu6JUhPkF9OXP4kezDjtDSduqTtJC-HgixPB7iymbjU_uoAiGbTKso1xIKokqpfJY6mJIKeLwNIcS82i7mczJdvNouznaXvo-PF_yqeuvyf-uwKL6zmM0yXlcHPY-FpOLLv4_I_4AcTDCiA</recordid><startdate>20240115</startdate><enddate>20240115</enddate><creator>Alishba</creator><creator>Ahmed, Usman</creator><creator>Taha, Muhammad</creator><creator>Khan, Naveed Ahmed</creator><creator>Salar, Uzma</creator><creator>Khan, Khalid Mohammed</creator><creator>Anwar, Ayaz</creator><creator>Siddiqui, Ruqaiyyah</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240115</creationdate><title>Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii</title><author>Alishba ; Ahmed, Usman ; Taha, Muhammad ; Khan, Naveed Ahmed ; Salar, Uzma ; Khan, Khalid Mohammed ; Anwar, Ayaz ; Siddiqui, Ruqaiyyah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-4c473b46ce403bc20052eda8813b75a528c793daca8ac0b14572185354123623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acanthamoeba</topic><topic>Amoebicidal</topic><topic>Benzothiazine</topic><topic>One-pot synthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alishba</creatorcontrib><creatorcontrib>Ahmed, Usman</creatorcontrib><creatorcontrib>Taha, Muhammad</creatorcontrib><creatorcontrib>Khan, Naveed Ahmed</creatorcontrib><creatorcontrib>Salar, Uzma</creatorcontrib><creatorcontrib>Khan, Khalid Mohammed</creatorcontrib><creatorcontrib>Anwar, Ayaz</creatorcontrib><creatorcontrib>Siddiqui, Ruqaiyyah</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Heliyon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alishba</au><au>Ahmed, Usman</au><au>Taha, Muhammad</au><au>Khan, Naveed Ahmed</au><au>Salar, Uzma</au><au>Khan, Khalid Mohammed</au><au>Anwar, Ayaz</au><au>Siddiqui, Ruqaiyyah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii</atitle><jtitle>Heliyon</jtitle><addtitle>Heliyon</addtitle><date>2024-01-15</date><risdate>2024</risdate><volume>10</volume><issue>1</issue><spage>e23258</spage><epage>e23258</epage><pages>e23258-e23258</pages><artnum>e23258</artnum><issn>2405-8440</issn><eissn>2405-8440</eissn><abstract>A rare but lethal central nervous system disease known as granulomatous amoebic encephalitis (GAE) and potentially blinding Acanthamoeba keratitis are diseases caused by free-living Acanthamoeba. Currently, no therapeutic agent can completely eradicate or prevent GAE. Synthetic compounds are a likely source of bioactive compounds for developing new drugs. This study synthesized seventeen 1,4-benzothiazine derivatives (I –XVII) by a base-catalyzed one-pot reaction of 2-amino thiophenol with substituted bromo acetophenones. Different spectroscopic techniques, such as EI-MS, 1H-, and 13C NMR (only for the new compounds), were used for the structural characterization and conformation of compounds. These compounds were assessed for the first time against Acanthamoeba castellanii. All compounds showed anti-amoebic potential in vitro against A. castellanii, reducing its ability to encyst and excyst at 100 μM. Compounds IX, X, and XVI showed the most potent activities among all derivatives and significantly reduced the viability to 5.3 × 104 (p < 0.0003), 2 × 105 (p < 0.006), and 2.4 × 105 (p < 0.002) cells/mL, respectively. The cytotoxicity profile revealed that these molecules showed lower to moderate cytotoxicity, i.e., 36 %, 2 %, and 21 %, respectively, against human keratinocytes in vitro. These results indicate that 1,4-benzothiazines showed potent in vitro activity against trophozoites and cysts of A. castellanii. Hence, these 1,4-benzothiazine derivatives should be considered to develop new potential therapeutic agents against Acanthamoeba infections.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38205285</pmid><doi>10.1016/j.heliyon.2023.e23258</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2405-8440 |
ispartof | Heliyon, 2024-01, Vol.10 (1), p.e23258-e23258, Article e23258 |
issn | 2405-8440 2405-8440 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_89b62601f2ec41b89647b81fd1a240ac |
source | Open Access: PubMed Central; ScienceDirect® |
subjects | Acanthamoeba Amoebicidal Benzothiazine One-pot synthesis |
title | Potential anti-amoebic effects of synthetic 1,4-benzothiazine derivatives against Acanthamoeba castellanii |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A21%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20anti-amoebic%20effects%20of%20synthetic%201,4-benzothiazine%20derivatives%20against%20Acanthamoeba%20castellanii&rft.jtitle=Heliyon&rft.au=Alishba&rft.date=2024-01-15&rft.volume=10&rft.issue=1&rft.spage=e23258&rft.epage=e23258&rft.pages=e23258-e23258&rft.artnum=e23258&rft.issn=2405-8440&rft.eissn=2405-8440&rft_id=info:doi/10.1016/j.heliyon.2023.e23258&rft_dat=%3Cproquest_doaj_%3E2913451506%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-4c473b46ce403bc20052eda8813b75a528c793daca8ac0b14572185354123623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2913451506&rft_id=info:pmid/38205285&rfr_iscdi=true |